Mucinex Exploratory Cold Study

Completed · Phase 2 · Has a placebo group

Conditions studied: Common Cold

In brief

This is an exploratory, multicenter, randomized, blinded, placebo-controlled study of Mucinex in patients with colds. Patients will receive 7 days of treatment with either Mucinex or placebo. The study will assess the effects of Mucinex on sputum and cold symptoms.

Key facts

Study ID

NCT01046136

Run by

Reckitt Benckiser Inc.

People needed

378

Starts

2009-12-01

Last updated by the study team

2020-12-30

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• common cold symptoms
• meet symptom severity
• females of child-bearing potential must have negative pregnancy test and use effective birth control

You may not qualify if…

• chronic respiratory conditions
• significant heart, kidney, liver, or lung disease, uncontrolled hypertension or diabetes, cystic fibrosis, thyroid disorder
• pregnant or lactating
• known malignancy
• participation in any other clinical trial within 30 days of baseline
• related to another enrolled patient or persons involved directly or indirectly with the conduct of this study

Where it is running

• Pioneer Clinical Research — Bellevue, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.